Whilst this announcement won't mean a lot of hard cash up front for BOT, it's REAL value is in that is another market that SB is being released into. Another country will now be using our product (well, the 5% version not our improved 15% version). This means more promotion, more patients, more success for SB in general. Where BOT will significantly benefit from this and further countries under Kaken's remit, is that it all starts to add up as SB getting a reputation as THE product of choice for hyperhidrosis sufferers.
Whilst this announcement won't mean a lot of hard cash up front...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $689.3M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 37.5¢ | $1.784M | 4.691M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 248028 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 356327 | 6 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |